Skylands Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Skylands Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-45,650	Closed	-$1.02M	–	201
2016 Q4	$1.02M	Buy	+45,650	New	+$893K	0.16%	109

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Skylands Capital's BEAT Position: Q1 2017 in Review

Skylands Capital sold out of BioTelemetry, Inc. (BEAT) in Q1 2017, closing a stake of 45,650 shares — an estimated $1.02M sold.

Skylands Capital first reported a position in BEAT in Q4 2016 and held it in 1 quarter. The position peaked at $1.02M in Q4 2016. 178 funds tracked by Wall St. Rank hold BEAT as of Q1 2017.

Skylands Capital reported no remaining BioTelemetry, Inc. position as of Q1 2017 after selling out during the quarter.
Skylands Capital sold 45,650 BioTelemetry, Inc. shares in Q1 2017, an estimated $1.02M.
Skylands Capital first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 1 quarter.
Skylands Capital's BioTelemetry, Inc. position peaked at $1.02M in Q4 2016.
178 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2017.

Based on Skylands Capital's 13F filing for Q1 2017, filed 17 Apr 2017.